483
Gershwin Blyden, M.D.Gershwin Blyden, M.D. – FDA 483, Sep 12, 2019
Record Details
An FDA inspection of Gershwin Blyden, M.D. in Hollywood, FL, a clinical investigator, revealed significant deficiencies in the conduct of a clinical study. Observations included subjects being deemed eligible for study participation before all required screening assessments were completed, inaccurate case histories with eligibility forms signed prior to their revision date, and inadequate investigational drug disposition records with discrepancies in dispensed product bottles.
View Company Profile
ID · 46639e4b-df45-4fe4-a265-eb609888fdf5
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.